| Synonyms: | |
| Status: | Approved (1989) |
| Entry Type: | Protein |
| Molecule Category: | Parent |
| ATC: | L02AE03 |
| UNII: | 0F65R8P09N |
| InChI Key | BLCLNMBMMGCOAS-URPVMXJPSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C59H84N18O14 |
| Molecular Weight | 1269.43 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leiomyoma | 3 | D007889 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Endometriosis | 3 | D004715 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Infertility | 3 | D007246 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Metabolic Syndrome | 2 | D024821 | ClinicalTrials |
| Primary Ovarian Insufficiency | 2 | D016649 | ClinicalTrials |
| Hodgkin Disease | 2 | D006689 | ClinicalTrials |
| Carcinoma, Lobular | 2 | D018275 | ClinicalTrials |
| Adenomyosis | 2 | D062788 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 65807-02-5 |
| ChEBI | 5523 |
| ChEMBL | CHEMBL1201247 |
| DrugBank | DB00014 |
| DrugCentral | 1327 |
| EPA CompTox | DTXSID7048297 |
| FDA SRS | 0F65R8P09N |
| Human Metabolome Database | HMDB0014259 |
| Guide to Pharmacology | 3879 |
| PubChem | 5311128 |
| SureChEMBL | SCHEMBL19712239 |